Skip To Content
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.
Before it's here, it's on the Bloomberg Terminal.
Learn More
ALONC:FPEN Paris

Oncodesign

COMPANY INFO
7.30EUR
Market Closed
As of 08/16/2019 EDT
Open
7.28
Prev Close
7.30
Volume
536
Market Cap
49.774M
Day Range
7.207.30
52 Week Range
5.7610.70
1D1M1Y5Y
View Full Chart
Market Closed
As of 08/16/2019 EDT
1D1M1Y5Y
View Full Chart
markets
Walmart Jumps Most in a Year on Strong 2Q Sales
Before it's here, it's on the Bloomberg Terminal.
Learn More
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.

Key Statistics

P/E Ratio--
Bloomberg (BEst) P/E Ratio28.0769
Bloomberg (BEst) PEG Ratio--
Shares Outstanding6.82M
Price to Book Ratio10.7900
Price to Sales Ratio2.4779
1 Year Return-19.78%
30 Day Avg Volume3,382
EPS-0.46
Bloomberg (BEst) EPS Curr Yr0.2600
Dividend--
Last Dividend Reported--
Earnings Announcement for Period Ending S1/2019:09/25/2019

About Oncodesign

Oncodesign SA focuses on approaches to cancer treatment. The Company uses experimentation of new cancer therapies and drug/biomarker discovery programs in partnership with the pharmaceutical industry.
Address
20 rue Jean Mazen BP Dijon, 21000 France
Phone
33-3-80-78-82-60
Website
www.oncodesign.com

Income Statement

Quarterly
Annual
Sorry, no quarterly data is available at this time.
Q3 2019 (Millions EUR)
  • Revenue
    --
  • Net Income
    --
  • Profit Margin
    --%

Balance Sheet

Quarterly
Annual
Sorry, no quarterly data is available at this time.
Q3 2019 (Millions EUR)
  • Total Assets
    --
  • Total Liabilities
    --
  • Debt to Assets
    --%

Cash Flow

Quarterly
Annual
Sorry, no quarterly data is available at this time.
Q3 2019 (Millions EUR)
  • Operating
    --
  • Investing
    --
  • Financing
    --